Acetamide,2,2'-[[1-(2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)-2-[1-hydroxy-2-(phosphonooxy)ethyl]-1,2-ethenediyl]bis(thio)]bis-(9CI) (111589-64-1)

Identification
Name:	Acetamide,2,2'-[[1-(2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)-2-[1-hydroxy-2-(phosphonooxy)ethyl]-1,2-ethenediyl]bis(thio)]bis-(9CI)
Synonyms:	di-(carboxamidomethyl)molybdopterin
CAS:	111589-64-1
Molecular Formula:	C14H22 N7 O8 P S2
Molecular Weight:	0
InChI:	InChI=1/C14H22N7O8PS2/c15-7(23)3-31-10(5-1-18-12-9(19-5)13(25)21-14(17)20-12)11(32-4-8(16)24)6(22)2-29-30(26,27)28/h5-6,19,22H,1-4H2,(H2,15,23)(H2,16,24)(H2,26,27,28)(H4,17,18,20,21,25)/b11-10+
Molecular Structure:
Properties
Flash Point:	535.3°C
Boiling Point:	961.5°C at 760 mmHg
Density:	2.07g/cm³
Refractive index:	1.844
Flash Point:	535.3°C
Safety Data

Other Product

L-Aspartic acid,N-[4-carboxy-1-oxo-2-(phosphonooxy)butyl]-L-a-glutamyl-, 1®5'-ester with5-[4-[[1-(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)ethyl]amino]phenyl]-5-deoxy-1-O-a-D-ribofuranosyl-D-ribitol (9CI)
L-Glutamic acid,N-[(2S)-4-carboxy-1-oxo-2-(phosphonooxy)butyl]-, P®5'-ester with1-[4-[[(1R)-1-[(6S,7S)-2-amino-1,4,5,6,7,8-hexahydro-7-methyl-4-oxo-6-pteridinyl]ethyl]amino]phenyl]-1-deoxy-5-O-a-D-ribofuranosyl-D-ribitol (9CI)
Benzamide,N-cyclobutyl-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-
1,2-Propanedione,1-[(6R)-2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]- (9CI)
D-Ribitol,5-[4-[[1-(2-amino-1,4-dihydro-7-methyl-4-oxo-6-pteridinyl)ethyl]amino]phenyl]-5-deoxy-1-O-a-D-ribofuranosyl- (9CI)
Vitamin B12,mixt. with N,N'-[dithiobis[1-methyl-2-[2- (phosphonooxy)ethyl]-2,1-ethenediyl]]bis[N-[(4- amino-2-methyl-5-pyrimidinyl)methyl]- formamide] and vitamin B6
L-Glutamic acid,N-[(2S)-4-carboxy-1-oxo-2-(phosphonooxy)butyl]-, P®5'-ester with1-[4-[[(1R)-1-(2-amino-1,4-dihydro-7-methyl-4-oxo-6-pteridinyl)ethyl]amino]phenyl]-1-deoxy-5-O-a-D-ribofuranosyl-D-ribitol (9CI)
1,2-Propanedione,1-(2-amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)-
Benzamide,4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-
2-Propanol,1-[[2,7-bis(2-methyl-4-morpholinyl)-6-phenyl-4-pteridinyl](2-hydroxyethyl)amino]-
Benzamide,4-[[7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(3-methylbutyl)-6-oxo-2-pteridinyl]amino]-N-[3-(1H-imidazol-1-yl)propyl]-3-methoxy-
Benzamide,N-cyclobutyl-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-
2-Propanol,1-[[2,7-bis(3-methyl-4-morpholinyl)-6-phenyl-4-pteridinyl](2-hydroxyethyl)amino]-
1(3H)-Isobenzofuranone,7-hydroxy-5-methoxy-4-methyl-6-[2-(phosphonooxy)ethyl]-
D-Ribitol,1-[4-[[1-(2-amino-1,4,5,6,7,8-hexahydro-5,7-dimethyl-4-oxo-6-pteridinyl)ethyl]amino]phenyl]-1-deoxy-5-O-[5-O-[(1,3-dicarboxypropoxy)hydroxyphosphinyl]-a-D-ribofuranosyl]-,[1[R(6S,7S)],5(S)]- (9CI)
D-Ribitol,1-[4-[[(1R)-1-[(6S,7S)-2-amino-1,4,5,6,7,8-hexahydro-7-methyl-4-oxo-6-pteridinyl]ethyl]amino]phenyl]-1-deoxy-5-O-[5-O-[[(1S)-1,3-dicarboxypropoxy]hydroxyphosphinyl]-a-D-ribofuranosyl]-
Thieno[3,2-g]pteridin-4(1H)-one,2-amino-6-hydroxy-7-[1-hydroxy-2-(phosphonooxy)ethyl]-
Acetamide,N-[4-[[[6-[[[2-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyl]amino]sulfonyl]-2-hydroxy-1-naphthalenyl]amino]sulfonyl]-8-hydroxy-7-[(2-methoxyphenyl)azo]-1-naphthalenyl]-
N-[4-[[1-(2-Amino-4-hydroxy-6-pteridinyl)ethyl]methylamino]benzoyl]-L-glutamic acid
L-Aspartic acid,N-[(2S)-4-carboxy-1-oxo-2-(phosphonooxy)butyl]-, P®5'-ester with1-[4-[[(1R)-1-(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)ethyl]amino]-2,5-dihydroxyphenyl]-1-deoxy-5-O-a-D-ribofuranosyl-D-ribitol (9CI)